<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Biovest International Inc. | Company News & Executive Profiles - BVTI | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/biovest+international+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Biovest International Inc.]]></description>
	<s:counts start="0" returned="10" found="14" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Accentia Biopharmaceuticals Reports Fiscal Second Quarter Financial Results]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_16/ai_n25431221]]></link>
		<description><![CDATA[Company to Present at Jefferies Healthcare Conference  TAMPA, Fla. -- Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announced today that the Company has filed its Quarterly Report (Form 10-Q) with the SEC, reporting the results of its operations, including consolidated results with its majority-owned subsidiary, Biovest International, Inc. (OTCBB:BVTI), for its second...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 16 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/accentia+biopharmaceuticals+inc..html"><![CDATA[Accentia Biopharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biovest+international+inc..html"><![CDATA[Biovest International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/conference.html"><![CDATA[conference]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">ABPI,BVTI,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Accentia Biopharmaceuticals Receives NASDAQ Compliance Notice]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_18/ai_n25335987]]></link>
		<description><![CDATA[TAMPA, Fla. -- Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) today announced that it received notice from The NASDAQ Stock Market dated April 15, 2008, notifying the Company that it is not in compliance with NASDAQ Rule 4450b(1)A, which requires a listed security to maintain a minimum $50 million market capitalization for continued...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 18 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biovest+international+inc..html"><![CDATA[Biovest International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/compliance.html"><![CDATA[compliance]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">BVTI,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_24/ai_n24945726]]></link>
		<description><![CDATA[TAMPA, Fla. -- Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) today announced that its Phase 3 clinical trial evaluating the Company's exclusively-licensed technology from the Mayo Clinic consisting of an intranasal antifungal lavage, SinuNase[TM] (topical amphotericin B 0.01% suspension) achieved, as anticipated, superior resolution of the cardinal symptoms of chronic sinusitis CS, as...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 24 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biovest+international+inc..html"><![CDATA[Biovest International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/endpoint.html"><![CDATA[endpoint]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/inflammation.html"><![CDATA[inflammation]]></category>
		<category domain="http://resources.bnet.com/topic/mayo+clinic.html"><![CDATA[Mayo Clinic]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
		<category domain="tickers">BVTI</category>
	</item>
	<item>
		<title><![CDATA[Accentia Biopharmaceutical's Revimmune Receives the Frost & Sullivan Multiple Sclerosis Product Innovation of the Year Award]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_13/ai_n24920856]]></link>
		<description><![CDATA[TAMPA, Fla. -- Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) today announced that Revimmune[TM], its potential blockbuster therapeutic candidate designed to treat up to 80 autoimmune diseases, has been awarded the Frost & Sullivan 2007 North American Multiple Sclerosis Product Innovation of the Year Award. If approved, Revimmune would be the first product...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 13 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biovest+international+inc..html"><![CDATA[Biovest International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/frost+%2526+sullivan.html"><![CDATA[Frost & Sullivan]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
		<category domain="tickers">BVTI</category>
	</item>
	<item>
		<title><![CDATA[Yesterdays Stock News Recap: ABPI, HMSY, CRMH, DWA, VIA.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200803/ai_n25262904]]></link>
		<description><![CDATA[M2 PRESSWIRE-12 March 2008-Businessnewsnow.us: Yesterdays Stock  News Recap: ABPI, HMSY, CRMH, DWA, VIAC1994-2008 M2 COMMUNICATIONS LTD    RDATE:12032008    New York, NY, March 12, 2008 - Accentia Biopharmaceuticals, Inc.  (NASDAQ: ABPI); HMS Holdings Corp. (NASDAQ: HMSY); CRM Holdings, Ltd.  (NASDAQ: CRMH); DreamWorks Animation...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 12 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/biovest+international+inc..html"><![CDATA[Biovest International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/compensation.html"><![CDATA[compensation]]></category>
		<category domain="http://resources.bnet.com/topic/crm.html"><![CDATA[CRM]]></category>
		<category domain="http://resources.bnet.com/topic/dreamworks+skg.html"><![CDATA[DreamWorks SKG]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/hms+holdings+corp..html"><![CDATA[HMS Holdings Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/insurance.html"><![CDATA[Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DWA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HMSY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">BVTI,DWA,HMSY,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Accentia Receives Official Designation as a Certified National Community Development Entity  from the United States Treasury Department]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Oct_8/ai_n21027761]]></link>
		<description><![CDATA[Designation Enables Company to Seek Suballocations of Grants from Established CDE's and to Make Direct Application for Grants from the Annual $3.5 Billion New Market Tax Credit NMTC Program at the U.S. Treasury to Facilitate Financings of Biotechnology Products and Companies  Accentia Pioneered the use of NMTCs to Support...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 08 Oct 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/biovest+international+inc..html"><![CDATA[Biovest International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/financing.html"><![CDATA[financing]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+treasury.html"><![CDATA[U.S. Department of Treasury]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
		<category domain="tickers">BVTI</category>
	</item>
	<item>
		<title><![CDATA[Interim Analysis of Anti-Cancer Vaccine, BiovaxID, to be Conducted]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_June_13/ai_n27272310]]></link>
		<description><![CDATA[Independent Data Monitoring Committee Requests Data Lock and Report of Interim Analysis  BiovaxID Phase 3 Clinical Trial Has No Identifiable Safety Concerns  WORCESTER, Mass. -- Biovest International, Inc. (OTCBB: BVTI), a majority owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announces a milestone in its effort to gain accelerated...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 13 Jun 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/analysis.html"><![CDATA[analysis]]></category>
		<category domain="http://resources.bnet.com/topic/biovest+international+inc..html"><![CDATA[Biovest International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nhl.html"><![CDATA[NHL]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
		<category domain="tickers">BVTI</category>
	</item>
	<item>
		<title><![CDATA[Accentia Biopharmaceuticals' Majority-Owned Subsidiary, Biovest, Receives Request From the Independent Data Monitoring Committee to Conduct Interim Analysis of Anti-Cancer Vaccine, BiovaxID]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_June_13/ai_n27272317]]></link>
		<description><![CDATA[Independent Data Monitoring Committee Requests Data Lock and Report of Interim Analysis  BiovaxID Phase 3 Clinical Trial Has No Identifiable Safety Concerns  TAMPA, Fla. -- Biovest International, Inc. (OTCBB: BVTI), a majority owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announces a milestone in its effort to gain accelerated...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 13 Jun 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/analysis.html"><![CDATA[analysis]]></category>
		<category domain="http://resources.bnet.com/topic/biovest+international+inc..html"><![CDATA[Biovest International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/monitoring.html"><![CDATA[monitoring]]></category>
		<category domain="http://resources.bnet.com/topic/nhl.html"><![CDATA[NHL]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
		<category domain="tickers">BVTI</category>
	</item>
	<item>
		<title><![CDATA[Investor Update.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200706/ai_n19757552]]></link>
		<description><![CDATA[M2 PRESSWIRE-12 June 2007-Businessnetwire.us: Investor  UpdateC1994-2007 M2 COMMUNICATIONS LTD    RDATE:12062007    New York, NY -- BusinessNetWire's "Investor's  Update" Focuses on the Following Companies:    COMMERCE PLANET, INC. (OTCBB: CPNE); BIOVEST INTERNATIONAL, INC.  (OTCBB: BVTI); ODYNE CORPORATION (OTCBB: ODYC); CYBERKINETICS ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 12 Jun 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biovest+international+inc..html"><![CDATA[Biovest International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cyberkinetics+neurotechnology+systems+inc..html"><![CDATA[Cyberkinetics Neurotechnology Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/vwr+international+inc..html"><![CDATA[VWR International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYKN</category>
		<category domain="tickers">BVTI,CYKN</category>
	</item>
	<item>
		<title><![CDATA[Biovest and VWR Enter Into Marketing and Distribution Agreement for AutovaxID]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_June_12/ai_n27270432]]></link>
		<description><![CDATA[Dedicated AutovaxID Manufacturing Facility in St. Louis to be Operational September 2007  WORCESTER, Mass. -- Biovest International, Inc. (OTCBB:BVTI) a majority owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI) has entered into a distribution agreement with VWR International, Inc., to distribute its breakthrough AutovaxID[TM] automated cell culture device in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 12 Jun 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biovest+international+inc..html"><![CDATA[Biovest International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/vwr+international.html"><![CDATA[VWR International]]></category>
		<category domain="http://resources.bnet.com/topic/vwr+international+inc..html"><![CDATA[VWR International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
		<category domain="tickers">BVTI</category>
	</item>
</channel>
</rss>
